Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice

The timing of vaccine availability is essential for an effective response to pandemic influenza. In 2009, vaccine became available after the disease peak, and this has motivated the development of next generation vaccine technologies for more rapid responses. The SAM(®) vaccine platform, now in pre-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hekele, Armin, Bertholet, Sylvie, Archer, Jacob, Gibson, Daniel G, Palladino, Giuseppe, Brito, Luis A, Otten, Gillis R, Brazzoli, Michela, Buccato, Scilla, Bonci, Alessandra, Casini, Daniele, Maione, Domenico, Qi, Zhi-Qing, Gill, John E, Caiazza, Nicky C, Urano, Jun, Hubby, Bolyn, Gao, George F, Shu, Yuelong, De Gregorio, Ennio, Mandl, Christian W, Mason, Peter W, Settembre, Ethan C, Ulmer, Jeffrey B, Craig Venter, J, Dormitzer, Philip R, Rappuoli, Rino, Geall, Andrew J
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2013
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3821287/
https://ncbi.nlm.nih.gov/pubmed/26038486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emi.2013.54
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge